Dec. 18 at 4:49 PM
$QURE What exactly is not to like here? Intuitions have already bought in. The FDA is re-framing their acceptance criteria at a policy level. This likely goes live next year after the FDA talks. Fully funded, ready to rock, waiting on some re-framing and meetings, then there is no reason it won't go back to previous valuations, maybe higher because of the shorts that will get squeezed out. What is the bear case on this one? Would honestly really appreciate the perspective as maybe there is a blind spot not being taken into account.
